Indicaton

Proclarix® is CE marked, intended for in vitro diagnostic use and indicated for prostate cancer diagnosis in patients with normal digital rectal exam (DRE), enlarged prostate volume and elevated levels of PSA at 2-10 ng/ml.

Therapeutic indications
Type of product
Table
  • Phase

    Marketed

  • Available in

    EU, Switzerland